Bharat Immunological & Biological Corporation standalone net profit declines 77.38% in the December 2017 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales decline 81.41% to Rs 4.47 crore
Net profit of Bharat Immunological & Biological Corporation declined 77.38% to Rs 0.50 crore in the quarter ended December 2017 as against Rs 2.21 crore during the previous quarter ended December 2016. Sales declined 81.41% to Rs 4.47 crore in the quarter ended December 2017 as against Rs 24.04 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales4.4724.04 -81 OPM %4.479.90 -PBDT0.451.59 -72 PBT0.381.57 -76 NP0.502.21 -77Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Jan 16 2018 | 4:45 PM IST